Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Status:
Completed
Trial end date:
2009-02-24
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the oral dosage of TR-701 to be used in Phase III
studies in patients with complicated skin and skin structure infections.